Skip to content
BIO experts discuss challenges and offer opportunities for developing redosable gene therapies
As drug makers work to develop safe, effective gene therapies, their progress can ...
Read More
BIO 2025: Federal seed funding also comes with valuable advice
The federal government’s program that provides seed funding to support research by biotech ...
Read More
BIO 2025: Legal experts break down cases against IRA price controls
Litigation opposing drug price controls in the Inflation Reduction Act (IRA) has yet ...
Read More
Emerging biotechs get bearish to weather market trends, finds BIO report
“Small companies are the lifeblood of the industry and a lot of what ...
Read More
Three questions men can ask about prostate cancer
Prostate cancer is the most common solid cancer among men, with 1 in ...
Read More
BIO visit shines a spotlight on Virginia’s biotech ecosystem
With more than $1 billion in R&D expenditures in 2022 and 415 new ...
Read More
EDITORS' CHOICE
A conversation with Fritz Bittenbender, new BIO Board Chair
The exciting new developments we’re seeing in biotechnology must be supported by equally innovative policy, according to Fritz Bittenbender, the new Chair of the Board ...
Read More
LATEST NEWS
Federal Policy
BIO experts discuss challenges and offer opportunities for developing redosable gene therapies
As drug makers work to develop safe, effective gene therapies, their progress can be slowed when they challenge the limits of established regulatory guidance on ...
Federal Policy
BIO 2025: Federal seed funding also comes with valuable advice
The federal government’s program that provides seed funding to support research by biotech startups provides much more than money, said program officials and small biotechs ...
BIO Events
BIO 2025: Legal experts break down cases against IRA price controls
Litigation opposing drug price controls in the Inflation Reduction Act (IRA) has yet to have a major impact, but the cases are still ongoing and ...
BIO Events
Emerging biotechs get bearish to weather market trends, finds BIO report
“Small companies are the lifeblood of the industry and a lot of what they do, and what they’re experiencing, greatly affects the industry as a ...
Health
Three questions men can ask about prostate cancer
Prostate cancer is the most common solid cancer among men, with 1 in 8 men being diagnosed in their lifetime and 1 in 44 dying ...
HEALTH
Welcome, John F. Crowley!
Get to know John F. Crowley, the new President and CEO of the Biotechnology Innovation Organization (BIO), in our exclusive interview.
Federal Policy
State Policy
Life sciences job report shows growth slowing, but firms still invest in talent
As the United States has long been a life sciences leader, the health of the life sciences sector is a ...
Read More
International
Bio's View
Emerging biotechs get bearish to weather market trends, finds BIO report
“Small companies are the lifeblood of the industry and a lot of what they do, and what they’re experiencing, greatly ...
Read More
